{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T18:11:39Z","timestamp":1792606299053,"version":"4.5.0"},"reference-count":51,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,8,11]],"date-time":"2023-08-11T00:00:00Z","timestamp":1691712000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>Human papillomavirus is a predominant sexually transmitted viral pathogen. Our objective was to analyze the relative distribution of genotypes over time and to determine the genotypes associated with adverse clinical lesions. The study was based on data from adult women with cytological abnormalities from whom histological samples were obtained from 2005 to 2021. HPV genotyping was performed using PCR and INNO-LiPA assay (Fujirebio). Among the 1,017 HPV-positive biopsies, 732 (72%) were infected with a single HPV genotype and 285 (28%) were infected with several HPV genotypes. Most of the infections involved the high-risk genotypes 16, 31, and 52. Throughout the study period, HPV 16 was the most encountered genotype (541, 53.2%), while HPV 18 was rather under-represented (46, 4.5%), especially in invasive cervical carcinoma. HVP52 (165, 16.2%) was detected mainly from 2008 to 2014, and its distribution reached 19.7% in 2011. Such epidemiological data underlines the possibility of an emergence of a high-risk genotype. The most detected low-risk HPV in combination with high-risk HPV was HPV 54 in 6.5% of samples. Monoinfection by HPV 16 led statistically more often to severe lesions than multi-infection involving HPV 16 (<jats:italic>p<\/jats:italic> &amp;lt; 0.001), while for HPV 52, 31 or 33, multi-infections were significantly associated with severe lesions (<jats:italic>p<\/jats:italic> &amp;lt; 0.001 for each of these three genotypes). HPV 16 was involved in 55.2% of high-grade lesions and <jats:italic>in situ<\/jats:italic> carcinoma and 76.3% of invasive carcinomas. In severe lesions, HPV 16 participation was predominant, whereas diverse genotypes were seen in low-grade lesions. Importantly, we observed that high-risk genotypes, for example HPV 52, can emerge for a few years then decrease even without vaccine pressure.<\/jats:p>","DOI":"10.3389\/fmed.2023.1224400","type":"journal-article","created":{"date-parts":[[2023,8,11]],"date-time":"2023-08-11T17:49:08Z","timestamp":1691776148000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Relative distribution of HPV genotypes in histological cervical samples and associated grade lesion in a women population over the last 16 years in Burgundy, France"],"prefix":"10.3389","volume":"10","author":[{"given":"Christelle","family":"Auvray","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serge","family":"Douvier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Odile","family":"Caritey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Baptiste","family":"Bour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Manoha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,8,11]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1002\/ijc.30716","article-title":"Worldwide burden of cancer attributable to HPV by site, country and HPV type","volume":"141","author":"de Martel","year":"2017","journal-title":"Int J Cancer"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1002\/jmv.24406","article-title":"High prevalence of human papillomavirus type 58 in HIV infected men who have sex with men: a preliminary report in Central Italy","volume":"88","author":"Sammarco","year":"2016","journal-title":"J Med Virol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.31557\/APJCP.2021.22.5.1351","article-title":"Prevalence of human papillomavirus (HPV) DNA among men with oropharyngeal and Anogenital cancers: a systematic review and Meta-analysis","volume":"22","author":"Sasidharanpillai","year":"2021","journal-title":"Asian Pac J Cancer Prev"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1038\/nrc2886","article-title":"Human papillomavirus oncoproteins: pathways to transformation","volume":"10","author":"Moody","year":"2010","journal-title":"Nat Rev Cancer"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"45","DOI":"10.2217\/fvl.10.73","article-title":"HPV-DNA integration and carcinogenesis: putative roles for inflammation and oxidative stress","volume":"6","author":"Williams","year":"2011","journal-title":"Future Virol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1016\/S1470-2045(10)70230-8","article-title":"Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study","volume":"11","author":"de Sanjose","year":"2010","journal-title":"Lancet Oncol"},{"key":"ref7","year":"2022"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1093\/jnci\/djn044","article-title":"Rapid clearance of human papillomavirus and implications for clinical focus on persistent infections","volume":"100","author":"Rodriguez","year":"2008","journal-title":"J Natl Cancer Inst"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1086\/444391","article-title":"Cervical coinfection with human papillomavirus (HPV) types and possible implications for the prevention of cervical cancer by HPV vaccines","volume":"192","author":"Mendez","year":"2005","journal-title":"J Infect Dis"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2020\/6508180","article-title":"Clinical significance of the interaction between human papillomavirus (HPV) type 16 and other high-risk human papillomaviruses in women with cervical intraepithelial neoplasia (CIN) and invasive cervical Cancer","volume":"2020","author":"Spinillo","year":"2020","journal-title":"J Oncol"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"289","DOI":"10.4132\/jptm.2022.08.02","article-title":"Evaluation of the characteristics of multiple human papillomavirus (HPV) infections identified using the BD Onclarity HPV assay and comparison with those of single HPV infection","volume":"56","author":"Kim","year":"2022","journal-title":"J Pathol Transl Med"},{"key":"ref12","volume-title":"Estimations nationales de l\u2019incidence et de la mortalit\u00e9 par cancer en France m\u00e9tropolitaine entre 1990 et 2018. Volume 1 \u2013 Tumeurs solides. Saint\u2011Maurice (Fra): Sant\u00e9 publique France","author":"Defossez","year":"2019"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"2640","DOI":"10.1016\/j.ejca.2009.07.018","article-title":"Trends of cervical cancer mortality in the member states of the European Union","volume":"45","author":"Arbyn","year":"2009","journal-title":"Eur J Cancer"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1093\/infdis\/jiw639","article-title":"Effectiveness of human papillomavirus vaccination on prevalence of vaccine genotypes in young sexually active women in France","volume":"215","author":"Heard","year":"2017","journal-title":"J Infect Dis"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1093\/eurpub\/cky173","article-title":"Health policy analysis of the non-implementation of HPV vaccination coverage in the pay for performance scheme in France","volume":"29","author":"Ohannessian","year":"2019","journal-title":"Eur J Pub Health"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1056\/NEJMoa021641","article-title":"Epidemiologic classification of human papillomavirus types associated with cervical cancer","volume":"348","author":"Munoz","year":"2003","journal-title":"N Engl J Med"},{"key":"ref17","first-page":"1","article-title":"Biological agents","volume":"100","year":"2012","journal-title":"IARC Monogr Eval Carcinog Risks Hum"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/S1470-2045(09)70096-8","article-title":"A review of human carcinogens\u2014part B: biological agents","volume":"10","author":"Bouvard","year":"2009","journal-title":"Lancet Oncol"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1002\/ijc.23093","article-title":"Human papillomavirus genotype distribution in high grade cervical lesions (CIN 2\/3) in France: EDITH study","volume":"122","author":"Pretet","year":"2008","journal-title":"Int J Cancer"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.1002\/ijc.27485","article-title":"Human papillomavirus types in 115,789 HPV-positive women: a meta-analysis from cervical infection to cancer","volume":"131","author":"Guan","year":"2012","journal-title":"Int J Cancer"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1002\/ijc.23092","article-title":"Human papillomavirus (HPV) genotype distribution in invasive cervical cancers in France: EDITH study","volume":"122","author":"Pretet","year":"2008","journal-title":"Int J Cancer"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1186\/s12885-017-3519-7","article-title":"High prevalence of co-infection between human papillomavirus (HPV) 51 and 52 in Mexican population","volume":"17","author":"Gallegos-Bolanos","year":"2017","journal-title":"BMC Cancer"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"e107573","DOI":"10.1371\/journal.pone.0107573","article-title":"Meta-analysis on prevalence and attribution of human papillomavirus types 52 and 58 in cervical neoplasia worldwide","volume":"9","author":"Chan","year":"2014","journal-title":"PLoS One"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"663","DOI":"10.21147\/j.issn.1000-9604.2019.04.10","article-title":"Distribution of high-risk human papillomavirus genotype prevalence and attribution to cervical precancerous lesions in rural North China","volume":"31","author":"Zhao","year":"2019","journal-title":"Chin J Cancer Res"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1093\/infdis\/jiu310","article-title":"Geographical distribution and risk association of human papillomavirus genotype 52-variant lineages","volume":"210","author":"Zhang","year":"2014","journal-title":"J Infect Dis"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"e0168178","DOI":"10.1371\/journal.pone.0168178","article-title":"Analysis of sequence variation and risk Association of Human Papillomavirus 52 variants circulating in Korea","volume":"11","author":"Choi","year":"2016","journal-title":"PLoS One"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"mgen000962","DOI":"10.1099\/mgen.0.000962","article-title":"The possible impact of novel mutations in human papillomavirus 52 on the infection characteristics","volume":"9","author":"Gong","year":"2023","journal-title":"Microb Genom"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"2337","DOI":"10.1080\/21645515.2015.1066948","article-title":"Comparison of HPV prevalence between HPV-vaccinated and non-vaccinated young adult women (20-26 years)","volume":"11","author":"Guo","year":"2015","journal-title":"Hum Vaccin Immunother"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1002\/(SICI)1097-0215(19990315)80:6<818::AID-IJC4>3.0.CO;2-T","article-title":"No excess risk of cervical carcinoma among women seropositive for both HPV16 and HPV6\/11","volume":"80","author":"Luostarinen","year":"1999","journal-title":"Int J Cancer"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1093\/infdis\/jiq139","article-title":"Human papillomavirus infection with multiple types: pattern of coinfection and risk of cervical disease","volume":"203","author":"Chaturvedi","year":"2011","journal-title":"J Infect Dis"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1158\/1055-9965.EPI-06-0129","article-title":"Human papillomavirus infections with multiple types and risk of cervical neoplasia","volume":"15","author":"Trottier","year":"2006","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1097\/LGT.0000000000000487","article-title":"Distribution of high-risk human papillomavirus genotypes and multiple infections in Preneoplastic and neoplastic cervical lesions of unvaccinated women: a cross-sectional study","volume":"23","author":"Iacobone","year":"2019","journal-title":"J Low Genit Tract Dis"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1159\/000442512","article-title":"Multiple human papilloma virus infections and their impact on the development of high-risk cervical lesions","volume":"59","author":"Salazar","year":"2015","journal-title":"Acta Cytol"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.ygyno.2019.10.003","article-title":"Co-infections of HPV16\/18 with other high-risk HPV types and the risk of cervical carcinogenesis: a large population-based study","volume":"155","author":"Wu","year":"2019","journal-title":"Gynecol Oncol"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/j.ygyno.2014.06.018","article-title":"Impact of human papillomavirus coinfections on the risk of high-grade squamous intraepithelial lesion and cervical cancer","volume":"134","author":"Carrillo-Garcia","year":"2014","journal-title":"Gynecol Oncol"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.virusres.2009.02.004","article-title":"Clustering patterns of human papillomavirus genotypes in multiple infections","volume":"142","author":"Spinillo","year":"2009","journal-title":"Virus Res"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1002\/ijc.25408","article-title":"Prospective study of human papillomavirus and risk of cervical adenocarcinoma","volume":"127","author":"Dahlstrom","year":"2010","journal-title":"Int J Cancer"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"K1","DOI":"10.1016\/j.vaccine.2008.05.064","article-title":"Epidemiology and natural history of human papillomavirus infections and type-specific implications in cervical neoplasia","volume":"26","author":"Bosch","year":"2008","journal-title":"Vaccine"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"e52","DOI":"10.3802\/jgo.2019.30.e52","article-title":"Human papillomavirus genotype-specific risk in cervical carcinogenesis","volume":"30","author":"So","year":"2019","journal-title":"J Gynecol Oncol"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"e0272205","DOI":"10.1371\/journal.pone.0272205","article-title":"Distribution of human papillomavirus genotypes by severity of cervical lesions in HPV screened positive women from the ESTAMPA study in Latin America","volume":"17","author":"Correa","year":"2022","journal-title":"PLoS One"},{"key":"ref41","first-page":"715","article-title":"HPV16 viral load and physical state measurement as a potential immediate triage strategy for HR-HPV-infected women: a study in 644 women with single HPV16 infections","volume":"8","author":"Manawapat-Klopfer","year":"2018","journal-title":"Am J Cancer Res"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1093\/infdis\/jiy507","article-title":"Role of human papillomavirus DNA load in predicting the long-term risk of cervical Cancer: a 15-year prospective cohort study in China","volume":"219","author":"Zhao","year":"2019","journal-title":"J Infect Dis"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"4149","DOI":"10.3390\/cancers13164149","article-title":"HPV16 load is a potential biomarker to predict risk of high-grade cervical lesions in high-risk HPV-infected women: a large longitudinal French hospital-based cohort study","volume":"13","author":"Baumann","year":"2021","journal-title":"Cancers (Basel)"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1002\/ijc.33519","article-title":"Human papillomavirus load and genotype analysis improves the prediction of invasive cervical cancer","volume":"149","author":"Hortlund","year":"2021","journal-title":"Int J Cancer"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.pvr.2018.10.001","article-title":"Single type infection of human papillomavirus as a cause for high-grade cervical intraepithelial neoplasia and invasive cancer in Japan","volume":"6","author":"Sakamoto","year":"2018","journal-title":"Papillomavirus Res"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.ygyno.2019.05.024","article-title":"Age-specific HPV type distribution in high-grade cervical disease in screened and unvaccinated women","volume":"154","author":"Aro","year":"2019","journal-title":"Gynecol Oncol"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"410","DOI":"10.20471\/acc.2019.58.03.02","article-title":"Factors associated with persistence of HPV genital infection in a small cohort of Romanian women","volume":"58","author":"Huic\u0103","year":"2019","journal-title":"Acta Clin Croat"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.ejogrb.2013.01.012","article-title":"Type-specific persistence and associated risk factors of human papillomavirus infections in women living in Central Italy","volume":"168","author":"Sammarco","year":"2013","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.gyobfe.2008.02.008","article-title":"Clairance, persistance et r\u00e9cidive de l'infection \u00e0 Papillomavirus [Clearance, persistence and recurrence of HPV infection]","volume":"36","author":"Denis","year":"2008","journal-title":"Gynecol Obstet Fertil"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s12885-021-09126-3","article-title":"Roles of extended human papillomavirus genotyping and multiple infections in early detection of cervical precancer and cancer and HPV vaccination","volume":"22","author":"Song","year":"2022","journal-title":"BMC Cancer"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"e0172906","DOI":"10.1371\/journal.pone.0172906","article-title":"Determinants of geographic inequalities in HPV vaccination in the most populated region of France","volume":"12","author":"Hequet","year":"2017","journal-title":"PLoS One"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2023.1224400\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,11]],"date-time":"2023-08-11T17:49:15Z","timestamp":1691776155000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2023.1224400\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,11]]},"references-count":51,"alternative-id":["10.3389\/fmed.2023.1224400"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2023.1224400","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,11]]},"article-number":"1224400"}}